Hints of a Helix, circa 1947

Hints of a Helix, circa 1947 By Elie Dolgin Nondegraded DNA from calf thymus. Appearing by Permission of the Museum of the History of Science, University of Oxford. MHS inv. 37391 Nearly four decades after biochemist Phoebus Levene first postulated his "tetranucleotide hypothesis" in 1910, most scientists still believed that DNA was made up of equal numbers of the four nucleotide bases in a repeating tetrameric structure, with ea

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

By Elie Dolgin

Nearly four decades after biochemist Phoebus Levene first postulated his "tetranucleotide hypothesis" in 1910, most scientists still believed that DNA was made up of equal numbers of the four nucleotide bases in a repeating tetrameric structure, with each subunit containing all four bases.

Then in 1947, John Masson Gulland, together with Dennis Oswald Jordan and their colleagues at University College, Nottingham, perfected a method of extracting DNA from calf thymus glands. Importantly, their protocol avoided the use of acid or alkali, which kept the solution at a constant neutral pH, allowing them to isolate pure, fibrous, nondegraded DNA (labeled 'desoxyribose nucleic acid' in Gulland's handwriting on the vial at right). When they added strong acids or bases to the sample, however, electrometric titrations showed that hydrogen bonds rather than covalent bonds linked the amino and hydroxyl groups of the nucleotide bases.

These results, along with Erwin Chargaff's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies